Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Transport of Pharmacologically Active Proline Derivatives by the Human Proton-Coupled Amino Acid Transporter hPAT1

Linda Metzner, Jutta Kalbitz and Matthias Brandsch
Journal of Pharmacology and Experimental Therapeutics April 2004, 309 (1) 28-35; DOI: https://doi.org/10.1124/jpet.103.059014
Linda Metzner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jutta Kalbitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Brandsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Several proline derivatives such as l-azetidine-2-carboxylic acid, cis-4-hydroxy-l-proline, and 3,4-dehydro-dl-proline prevent procollagen from folding into a stable triple-helical conformation, thereby reducing excessive deposition of collagen in fibrotic processes and the growth of tumors. This study was performed to investigate whether the recently discovered human proton-coupled amino acid transporter 1 (hPAT1) is capable of transporting such pharmacologically relevant proline derivatives and also GABA analogs. Uptake of l-[3H]proline and [3H]glycine in Caco-2 cells was Na+-independent but strongly H+-dependent. The l-proline uptake was saturable and mediated by a single transport system (hPAT1) with an affinity constant of 2.0 ± 0.2 mM. The uptake of l-[3H]proline was inhibited by d-proline, trans-4-hydroxy-l-proline, cis-4-hydroxy-l-proline, cis-4-hydroxy-d-proline, 3,4-dehydro-dl-proline, l-azetidine-2-carboxylic acid, 3-amino-1-propanesulfonic acid, d- and l-pipecolic acid, l-thiaproline, and many others. Apical uptake and transepithelial flux of l-[3H]proline across Caco-2 cell monolayers were strongly inhibited by proline derivatives in proportions corresponding to their respective affinity constants at hPAT1. The basolateral to apical flux of l-[3H]proline was only 8% of that in the opposite direction. Apical uptake of unlabeled l-proline, cis-4-hydroxy-l-proline, and l-azetidine-2-carboxylic acid was stimulated by an inside directed H+ gradient 2- to 3-fold. Total apical to basolateral flux of proline derivatives was moderately correlated with their inhibitory potency for l-[3H]proline uptake and flux inhibition. We conclude that 1) the substrate specificity of hPAT1 is very much broader than so far reported and 2) the system accepts therapeutically relevant proline and GABA derivatives. hPAT1 is a promising candidate for new ways of oral drug delivery.

Footnotes

  • This study was supported by the Federal Ministry of Education and Research Grant BMBF 0312750A, Land Sachsen-Anhalt Grant 3505A/0403L, the Institute of Pharmaceutical Biology (Department of Pharmacy, Martin-Luther-University Halle-Wittenberg) and the Fonds der Chemischen Industrie. This work is part of the doctoral thesis of L.M.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • DOI: 10.1124/jpet.103.059014.

  • ABBREVIATIONS: APSA, 3-amino-1-propanesulfonic acid; MeAIB, α-(methylamino)isobutyric acid; hPAT1, human proton-coupled amino acid transporter 1; LACA, l-azetidine-2-carboxylic acid; CHLP, cis-4-hydroxy-l-proline; GHB, γ-hydroxybutyric acid; CHDP, cis-4-hydroxy-d-proline; MES, 2-(N-morpholino)ethanesulfonic acid; HPLC, high-performance liquid chromatography; THLP, trans-4-hydroxy-l-proline.

    • Received August 22, 2003.
    • Accepted December 10, 2003.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 309 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 309, Issue 1
1 Apr 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transport of Pharmacologically Active Proline Derivatives by the Human Proton-Coupled Amino Acid Transporter hPAT1
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Transport of Pharmacologically Active Proline Derivatives by the Human Proton-Coupled Amino Acid Transporter hPAT1

Linda Metzner, Jutta Kalbitz and Matthias Brandsch
Journal of Pharmacology and Experimental Therapeutics April 1, 2004, 309 (1) 28-35; DOI: https://doi.org/10.1124/jpet.103.059014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Transport of Pharmacologically Active Proline Derivatives by the Human Proton-Coupled Amino Acid Transporter hPAT1

Linda Metzner, Jutta Kalbitz and Matthias Brandsch
Journal of Pharmacology and Experimental Therapeutics April 1, 2004, 309 (1) 28-35; DOI: https://doi.org/10.1124/jpet.103.059014
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Increased momentary urethral closure by 5-HT2C agonist
  • Canalicular Transporters Studied with Fluorescent Bile Acids
  • Knockout of Add3 Promotes L-NAME–Induced Renal Injury
Show more Gastrointestinal, Hepatic, Pulmonary, and Renal

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics